Open AccessCorrection: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis
Author(s) -
Reza Bayat Mokhtari,
Bessi Qorri,
Narges Baluch,
Angelo Sparaneo,
Federico Pio Fabrizio,
Lucia Anna Muscarella,
Albina Tyker,
Sushil Kumar,
Hailing Cheng,
Myron R. Szewczuk,
Bikul Das,
Herman Yeger
Publication year - 2022
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.28104
Subject(s) - pi3k/akt/mtor pathway , sulforaphane , medicine , cancer , protein kinase b , apoptosis , cancer research , oncology , biology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom